NIH-funded research R03 grant

Hollow Microneedles to Read Biochemical Things in Interstitial Fluid

Official title: Hollow Microneedles for Interstitial Fluid Biosensing

Funded at Boston University (Charles River Campus) · NIH-11454544 · Data updated 2026-11-12

A small grant tests tiny hollow needles that can sample interstitial fluid from the skin to sense biochemical markers for wearables.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionBoston University (Charles River Campus)
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$81,750
NIH project number1R03EB038582-01A1
Project IDNIH-11454544 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with conditions where skin-based biomarker monitoring could inform care or wellness, such as metabolism-related biomarkers.

Less likely to help

People whose skin is unsuitable for microneedle sensing or whose biomarkers do not rely on ISF measurements may not benefit.

What this research studies

This project focuses on making a wearable-friendly sensor that can access interstitial fluid through microneedles. It aims to demonstrate how hollow microneedles can reliably collect ISF and measure biomarkers like glucose and lactate in a skin-embedded setup, using animal models and artificial skin for validation. The work blends materials science with biosensing techniques to bring closer real-time biochemical readouts to wearable devices. If successful, it could pave the way for noninvasive, continuous health monitoring that reflects blood-like information without drawing blood.

Why it matters

Potential benefit: If successful, wearable devices could monitor important biomarkers more accurately through the skin.

How similar studies have gone: Previous work has shown sampling ISF with microneedles in models, suggesting feasibility with continued optimization.

Where this research is happening

  • Boston University (Charles River Campus)
    Boston, United States
    Active

Researchers

  • Principal investigator: Galagan, James E — Boston University (Charles River Campus)
  • Study coordinator: Galagan, James E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.